Benelux Coronary and Peripheral Stents Market Outlook (2022-2033)

The Benelux coronary and peripheral stents market size is expected to reach US$ 292.5 million by 2033 from US$ 134.4 million in 2024. The market is estimated to record a CAGR of 9.0% from 2025 to 2033.

Executive Summary and Benelux Coronary and Peripheral Stents Market Analysis:

The Benelux coronary and peripheral stents market is a mature and well-regulated segment of the European cardiovascular devices landscape, with the Netherlands playing a dominant role. The region benefits from advanced healthcare infrastructure, high procedural standards, and strong adherence to evidence-based interventional cardiology guidelines. Demand for coronary and peripheral stents is driven by an aging population and a consistently high burden of atherosclerotic disease managed increasingly through minimally invasive approaches. Hospitals across Benelux emphasize clinical outcomes, long-term device performance, and safety, which supports steady replacement demand for next-generation stent technologies. However, the market faces restraints related to pricing pressure from centralized procurement systems and strict health technology assessments that limit rapid adoption of premium-priced innovations. Despite these constraints, ongoing emphasis on procedural efficiency, outpatient cardiac care pathways, and continuous clinician training sustains stable market activity. The Netherlands’ leadership further reinforces Benelux as a benchmark region for standardized stent utilization.

Benelux Coronary and Peripheral Stents Market Segmentation Analysis

Key segments that contributed to the derivation of the coronary and peripheral stents market analysis are product type, material type, application and end user.

• By product type, the coronary and peripheral stents market is segmented into bare-metal stents, drug-eluting stents, bioresorbable vascular scaffolds, and others. The drug-eluting stents segment dominated the market in 2024. Superior efficacy in reducing restenosis, longer-term patient outcomes, and widespread physician preference drove adoption, making them the most trusted choice compared to bare-metal or bioresorbable alternatives.
• By material type, the coronary and peripheral stents market is segmented into metal, polymer, and hybrid. The metal segment dominated the market in 2024. High durability, proven biocompatibility, cost-effectiveness, and established clinical success ensured dominance, as polymer and hybrid options remain limited in availability, scalability, and long-term performance validation.
• By application, the coronary and peripheral stents market is segmented into coronary artery disease and peripheral artery disease. The coronary artery disease segment dominated the market in 2024. Higher global prevalence, significant clinical burden, and greater demand for interventional procedures positioned coronary stents as the leading application, overshadowing peripheral artery disease interventions in overall market share.
• By end user, the market is segmented into hospitals, ambulatory surgical centers, cardiac catheterization labs, and specialty clinics. The hospitals segment held the largest share of the market in 2024. Comprehensive infrastructure, advanced catheterization facilities, skilled specialists, and ability to handle complex cases ensured hospitals remained the primary setting for stent implantation, surpassing smaller clinics and ambulatory centers.

 Benelux Coronary and Peripheral Stents Market Outlook

The Benelux coronary and peripheral stents market is characterized by high penetration of percutaneous interventions and limited variability in clinical practice across hospitals. Coronary stents represent the primary application, while peripheral stents are increasingly used in structured vascular programs addressing complex arterial disease. A key driver for the market is the strong integration of interventional cardiology within national healthcare systems, particularly in the Netherlands. Early diagnosis, streamlined referral networks, and widespread availability of catheterization laboratories enable timely intervention. This integrated care model reduces reliance on open surgical procedures and supports consistent stent usage. Additionally, hospitals actively participate in clinical registries and post-market surveillance, encouraging the adoption of stents with robust long-term clinical data. This evidence-driven environment supports continuous but controlled demand for advanced stent platforms, maintaining market stability across the Benelux region.

Benelux Coronary and Peripheral Stents Market Country Insights

Based on country, the Benelux coronary and peripheral stents market is further segmented into Belgium, the Netherlands, and Luxembourg. The Netherlands held the largest share in 2024.

The Netherlands dominates the Benelux coronary and peripheral stents market due to its highly organized healthcare system and advanced interventional cardiology infrastructure. Dutch hospitals are equipped with modern catheterization laboratories and operate under standardized national treatment protocols, ensuring uniform stent utilization. Drug-eluting coronary stents are widely adopted as standard of care, while peripheral stents are increasingly used within multidisciplinary vascular teams. The country places strong emphasis on clinical outcomes, cost-effectiveness, and long-term device performance, influencing purchasing decisions. The Netherlands is also active in cardiovascular clinical research and real-world evidence generation, shaping regional treatment standards. Centralized procurement and value-based purchasing create competitive pressure among suppliers, but also ensure high-quality device adoption. Overall, the Netherlands’ focus on efficiency, evidence, and patient outcomes firmly positions it as the leading stents market within Benelux.

Benelux Coronary and Peripheral Stents Market Company Profiles

Medtronic, Boston Scientific Corporation, Abbott, B. Braun SE, TERUMO CORPORATION, Teleflex Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Cook Medical, Meril Life Sciences and Translumina are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.

Benelux Coronary and Peripheral Stents Market Research Methodology:

The following methodology has been followed for the collection and analysis of data presented in this report:

• Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

• Primary Research

Business Market Insights conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:

• Refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

Benelux Coronary and Peripheral Stents Key Sources Referred:

• The World Bank
• World Health Organization (WHO)
• Center for Disease Control and Prevention (CDC)
• European Society of Cardiology
• American College of Cardiology
• American Heart Association
• Asian Pacific Society of Interventional Cardiology
• Company website
• Company annual reports
• Company investor presentations